Status:
RECRUITING
Gait Assessment Via Telephone Application
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Health, Subjective
Eligibility:
All Genders
18-26 years
Brief Summary
The evaluation of human gait is a crucial component of the clinical assessment and decision-making process. The gold standard in gait analysis is computerized gait analysis, which allows for three-dim...
Detailed Description
Voluntary healthy participants will be included in the study. Signed voluntary consent will be obtained from participants. Participants will be divided into two groups. 3D Computerized Gait Analysis w...
Eligibility Criteria
Inclusion
- Age between 18 and 26 years.
- Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2)
Exclusion
- Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus).
- History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months.
- History of lower extremity injury within the last 6 months.
- Leg length discrepancy.
- Presence of third-degree pes planus.
- Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases.
- History of pain, deformity, or surgery related to the vertebral column and upper extremities.
- Presence of cognitive, mental, and/or severe psychiatric disorders
Key Trial Info
Start Date :
July 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06157749
Start Date
July 31 2024
End Date
September 1 2025
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem Mehmet Ali Aydinlar University
Istanbul, Turkey (Türkiye), 34752